Asia has a significantly greater prevalence of Cholangiocarcinoma, in comparison to the other parts of the world, with China, South Korea, Thailand, and Taiwan having the highest incidence rates in the region.
November 27, 2023
News
Novotech Identifies Decentralized Clinical Trials Potential and Challenges for Accelerating Global…
Hong Kong - Novotech, the leading Asia P
Read more